1. Uncovering potential novel biomarkers and immune infiltration characteristics in persistent atrial fibrillation using integrated bioinformatics analysis
   Shengjue Xiao et al, 2021, Mathematical Biosciences and Engineering CrossRef
2. Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
   Cun-Cun Hua et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
3. Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity
   Vincenzo Quagliariello et al, 2018, Nutrients CrossRef
4. Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach
   Luisa Marracino et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Identifying ceRNA Networks Associated With the Susceptibility and Persistence of Atrial Fibrillation Through Weighted Gene Co-Expression Network Analysis
   Yaozhong Liu et al, 2021, Frontiers in Genetics CrossRef
6. MicroRNA-34a in cardiovascular disease: a glimpse into the future
   A.M. Alieva et al, 2023, Kardiologicheskii vestnik CrossRef
7. Glycyrrhetinic acid alleviates atrial fibrillation by inhibiting the expression of PIM1
   Hao Liang et al, 2024, Chemical Biology & Drug Design CrossRef
8. Genetics and Epigenetics of Atrial Fibrillation
   Estefanía Lozano-Velasco et al, 2020, International Journal of Molecular Sciences CrossRef
9. In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation
   Rocchina Vilella et al, 2022, Pharmaceuticals CrossRef
10. Genetic Complexity of Sinoatrial Node Dysfunction
    Michael J. Wallace et al, 2021, Frontiers in Genetics CrossRef